Congressmen Tim Ryan and Steve Stivers plan to re-introduce the Gluten in Medicine Disclosure Act for the 117th Congress on Thursday, April 8, 2021.
If passed, the bill would amend the Federal Food, Drug, and Cosmetic Act to require gluten to be labeled in all medications.
“Our community needs to have confidence that their medicines are helping them, not hurting them. Not knowing if your medication contains gluten forces you to take risks with your or your child’s health. Imagine if you or your child with celiac disease needs medication. Right now, there’s no way to know for sure if the medicine will trigger a gluten-related reaction, which may result in serious symptoms. This legislation is long overdue.”—Alice Bast, Beyond Celiac CEO
Beyond Celiac encourages you to support the Gluten in Medicine Disclosure Act of 2021 by contacting your representatives and encouraging them to cosponsor this bill. A list of those currently cosponsoring this bill can be found here.